medvi Tirzepatide cost
Last updated: June 23, 2026
Quick Answer
MEDVi tirzepatide cost starts at approximately $249 to $449 per month depending on dosage tier, making it one of the more competitively priced compounded tirzepatide programs available through telehealth in 2026. The program includes physician consultation, medication, and ongoing support with no insurance required. Compared to brand-name Zepbound, which can exceed $1,000 monthly without insurance, MEDVi offers a meaningful cost advantage for qualifying patients.
Our Verdict: 4.8/5 — Highly Recommended for Cost-Conscious GLP-1 Seekers
Best for: Adults with a BMI over 27 seeking affordable compounded tirzepatide without insurance
Best for: Patients who want telehealth convenience with physician oversight
Best for: People comparing GLP-1 platforms before committing to a monthly plan
Skip if: You are pregnant, nursing, or have a personal or family history of medullary thyroid carcinoma
Skip if: You prefer brand-name FDA-approved injections over compounded formulations
Key Takeaways
- MEDVi tirzepatide cost typically ranges from $249 to $449 per month based on dosage, making it significantly cheaper than brand-name Zepbound or Mounjaro without insurance
- MEDVi is a telehealth platform that connects patients with licensed physicians who prescribe compounded tirzepatide through accredited compounding pharmacies
- No insurance is required, and the monthly fee generally covers consultation, medication, and care coordination
- Compounded tirzepatide is not FDA-approved as a finished drug product, but the active ingredient mirrors the same molecule used in Zepbound
- Clinical data on tirzepatide shows average weight loss of up to 20.9% of body weight over 72 weeks in the SURMOUNT-1 trial (NEJM, 2022)
- MEDVi offers a structured dose-escalation protocol, which helps minimize common GI side effects during the early weeks
- Coupon codes and promotional discounts can reduce MEDVi tirzepatide cost by up to 30% for first-time subscribers [3]
- Patients report high satisfaction with the intake process and physician responsiveness, though some note variability in shipping timelines [10]
- MEDVi is best compared against platforms like Measured, Shed GLP-1, and Ro Body when evaluating total value
- Always verify that any compounding pharmacy used is PCAB-accredited or operates under USP 797 standards before purchasing
What Is MEDVi and How Does Its Tirzepatide Program Work?
MEDVi is a telehealth weight-loss platform that prescribes compounded tirzepatide to eligible adults through a fully online process. Patients complete a health intake form, consult with a licensed physician, and receive medication shipped directly to their door from a compounding pharmacy.
Tirzepatide is a dual GIP and GLP-1 receptor agonist. It works by targeting two hormonal pathways simultaneously, which helps reduce appetite, slow gastric emptying, and improve insulin sensitivity. This dual-action mechanism is what makes tirzepatide generally more effective for weight loss than single-receptor GLP-1 drugs like semaglutide.
MEDVi’s compounded version uses the same active molecule as Eli Lilly’s Zepbound, but it is prepared by a third-party compounding pharmacy rather than manufactured by the brand. This distinction is important for cost and regulatory reasons, which we cover below.
How the process works:
- Complete MEDVi’s online health questionnaire (takes about 10 minutes)
- A licensed physician reviews your intake and medical history
- If approved, a prescription is sent to a compounding pharmacy
- Medication ships directly to your home, typically within 5 to 7 business days
- Ongoing check-ins and dose adjustments are included in the monthly plan
Ready to get started? Visit MEDVi’s official program page and complete your intake today.
What Is the MEDVi Tirzepatide Cost Per Month?
MEDVi tirzepatide cost per month generally falls between $249 and $449, depending on the dosage tier prescribed. Lower starting doses cost less, while higher maintenance doses sit at the upper end of that range. [5][7]
Here is a general breakdown of reported pricing tiers:
| Dosage Tier | Estimated Monthly Cost |
|---|---|
| Starting dose (2.5 mg) | ~$249/month |
| Mid-range dose (5 mg–7.5 mg) | ~$349/month |
| Higher dose (10 mg–15 mg) | ~$449/month |
| With first-time coupon (up to 30% off) | As low as ~$175/month |
These figures are based on reported pricing from multiple independent review sources [5][7][8]. Actual costs may vary based on your location, the compounding pharmacy used, and any promotional pricing active at the time of enrollment.
How MEDVi tirzepatide cost compares to alternatives:
- Brand-name Zepbound (Eli Lilly): $1,059 to $1,349/month without insurance
- Brand-name Mounjaro: $1,000+ per month without insurance
- Other compounded tirzepatide telehealth platforms: $299 to $599/month
- Cheapest tirzepatide options online can start lower but often lack physician oversight
For a broader look at how these numbers stack up, see our full tirzepatide cost comparison for 2026.
Common mistake: Many patients compare only the medication cost and forget to factor in consultation fees. MEDVi bundles physician visits into the monthly price, which adds real value compared to platforms that charge separately for each check-in.
Is MEDVi Tirzepatide Worth the Cost? A 30-Day Honest Look
Based on aggregated user reports and independent review data, MEDVi delivers a solid experience for most patients who qualify. Here is what the evidence shows across a typical first month. [4][6][10]
Week 1 (The Adjustment Phase)
Most users report mild nausea and reduced appetite within the first few days of starting at the 2.5 mg dose. This is expected with any GLP-1 or dual agonist medication. MEDVi’s dose-escalation protocol helps by keeping the starting dose low.
Week 2 (The Settling Period)
GI symptoms typically ease. Users begin noticing a meaningful reduction in hunger and fewer cravings for high-calorie foods. Some report improved energy, though this varies.
Weeks 3 to 4 (Measurable Results)
Independent user reviews report early weight loss ranging from 4 to 8 pounds in the first month, consistent with clinical expectations for tirzepatide at low doses. [6]
Pros:
- Significantly lower cost than brand-name tirzepatide
- Fully online process with licensed physician oversight
- Dose escalation built into the program
- No insurance required
- Coupon codes available for additional savings [3]
Cons:
- Compounded tirzepatide is not FDA-approved as a finished drug product
- Shipping timelines can vary by region
- Not available in all U.S. states
Start your MEDVi consultation now — the intake takes less than 10 minutes and there is no obligation until you are approved.
How Does MEDVi Compare to Other Compounded Tirzepatide Providers?
MEDVi sits in a competitive middle tier: more affordable than some premium telehealth platforms, and more clinically structured than bare-bones prescription-only services. [1][9]
| Feature | MEDVi | Measured GLP-1 | Ro Body | Brand Zepbound |
|---|---|---|---|---|
| Monthly cost | $249–$449 | ~$299–$499 | ~$299+ | $1,059–$1,349 |
| Physician included | Yes | Yes | Yes | Via separate provider |
| Compounded or brand | Compounded | Compounded | Compounded | Brand |
| Insurance required | No | No | No | Often needed |
| FDA-approved drug | No | No | No | Yes |
For a deeper look at Measured’s program, see our Measured GLP-1 review for 2026.
If you are weighing the cost of GLP-1 medications more broadly without insurance, our full GLP-1 cost guide covers all major options in detail.
Choose MEDVi if: You want a low-cost compounded tirzepatide program with physician oversight and no insurance hassle.
Consider alternatives if: You specifically need an FDA-approved brand-name product, or if you live in a state where MEDVi does not operate.
Who Qualifies for MEDVi Tirzepatide?
MEDVi tirzepatide is intended for adults who meet specific clinical criteria. Not everyone who applies will be approved, and that is by design — physician oversight is part of what makes the program credible.
General eligibility requirements:
- BMI of 27 or higher (or 25+ with a weight-related condition)
- No personal or family history of medullary thyroid carcinoma or MEN2 syndrome
- Not pregnant or breastfeeding
- No active pancreatitis or severe GI conditions
- Willing to commit to ongoing follow-up and dose monitoring
Patients with Type 2 diabetes may also qualify, as tirzepatide was originally approved for blood sugar management before its weight-loss indication.
Not sure if you qualify? Take the MEDVi eligibility quiz here — it is free and takes under 5 minutes.
How to Reduce MEDVi Tirzepatide Cost Further
The listed price is not always the final price. Several strategies can meaningfully reduce what you pay each month.
Ways to lower your MEDVi tirzepatide cost:
- Use a coupon code at checkout. MEDVi coupon codes in 2026 have been reported to save up to 30% on GLP-1 weight-loss plans [3]. Check current offers before completing enrollment.
- Start at the lowest dose. The 2.5 mg starting tier is the least expensive. Many patients stay at lower doses longer than expected and still see strong results.
- Commit to a multi-month plan. Some telehealth platforms, including MEDVi, offer discounts for longer subscription commitments.
- Compare total program costs, not just medication. Platforms that charge separately for consultations can end up costing more overall.
For a broader comparison of budget-friendly GLP-1 options, see our guide to cheapest GLP-1 medications without insurance.
Claim your MEDVi discount and check current pricing before the offer changes.
Is Compounded Tirzepatide from MEDVi Safe?
Compounded tirzepatide from MEDVi is prepared by licensed compounding pharmacies, not manufactured by Eli Lilly. The safety profile depends heavily on the quality of the compounding pharmacy involved.
What to look for in a safe compounding program:
- Pharmacy holds PCAB accreditation or operates under USP 797/800 standards
- Medication is tested for potency, sterility, and purity by a third-party lab
- A licensed physician, not just a nurse practitioner, reviews your case
- The platform does not allow self-dosing without clinical guidance
MEDVi partners with accredited compounding pharmacies and requires physician review before any prescription is issued [1][4]. This is a meaningful distinction from lower-cost platforms that operate with minimal clinical oversight.
The FDA has noted that compounded drugs are not FDA-approved as finished products, meaning they do not go through the same pre-market approval process as Zepbound. However, the active ingredient, tirzepatide, is the same molecule. Patients should understand this distinction before enrolling.
For guidance on evaluating any compounding pharmacy, see our resource on how to verify a legitimate compounding pharmacy.
What Do Real Users Say About MEDVi Tirzepatide?
User reviews across independent platforms paint a largely positive picture, with some consistent patterns worth noting. [4][6][10]
Positive themes:
- “The intake process was fast and the physician actually responded to my questions the same day.” [10]
- “I lost 11 pounds in my first six weeks. The cost is a fraction of what my pharmacy quoted for Zepbound.” [6]
- “Shipping was slower than expected the first month, but the second shipment arrived on time.” [4]
Critical themes:
- Some users report mild injection site discomfort, which is common with any subcutaneous injection
- A small number of users note that the approval process took longer than the advertised timeline in certain states
- A few reviewers wanted more frequent check-ins than the program currently offers
Overall, MEDVi holds strong ratings across consumer review platforms, with most complaints centering on logistics rather than clinical outcomes. [10]
Conclusion: Is MEDVi Tirzepatide Worth It in 2026?
MEDVi tirzepatide cost is one of the most competitive in the compounded GLP-1 market, starting at $249 per month and reaching $449 at higher doses. For adults who cannot afford brand-name Zepbound or Mounjaro, MEDVi offers a physician-supervised, pharmacy-fulfilled alternative that delivers the same active molecule at a fraction of the price.
The program is not perfect. Compounded tirzepatide carries regulatory nuances that brand-name products do not, and shipping timelines can vary. But for the right patient — someone with a qualifying BMI, no contraindications, and a clear weight-loss goal — MEDVi represents strong value.
Your next steps:
- Check your eligibility using MEDVi’s free online intake form
- Apply any available coupon codes to reduce your first-month cost
- Start at the lowest dose tier and allow 4 to 6 weeks before evaluating results
- Schedule your follow-up check-in and track your weight weekly
Frequently Asked Questions
How much does MEDVi tirzepatide cost per month?
MEDVi tirzepatide cost ranges from approximately $249 to $449 per month depending on your prescribed dosage tier. First-time users may access coupon codes that reduce the starting cost by up to 30%. [3][5]
Is MEDVi tirzepatide FDA-approved?
No. MEDVi uses compounded tirzepatide, which is not FDA-approved as a finished drug product. The active ingredient is the same molecule found in FDA-approved Zepbound, but compounded versions are prepared by third-party pharmacies rather than the brand manufacturer.
Does MEDVi require insurance?
No. MEDVi operates as a cash-pay telehealth platform. No insurance is required, and the monthly fee typically covers physician consultation and medication.
How does MEDVi tirzepatide compare to Zepbound in cost?
Brand-name Zepbound costs $1,059 to $1,349 per month without insurance. MEDVi tirzepatide starts at $249 per month, making it 60% to 80% less expensive for patients paying out of pocket. [5][7]
How long does it take to see results with MEDVi tirzepatide?
Most users report noticeable appetite reduction within the first two weeks. Measurable weight loss typically becomes evident by weeks three to four. Clinical data on tirzepatide shows significant weight loss over 12 to 72 weeks depending on dose and adherence.
Can I use a coupon code on MEDVi?
Yes. MEDVi coupon codes are available in 2026 and can save up to 30% on GLP-1 weight-loss plans. Check the current offers on the MEDVi website before completing checkout. [3]
Who should not use MEDVi tirzepatide?
You should not use MEDVi tirzepatide if you are pregnant, breastfeeding, have a personal or family history of medullary thyroid carcinoma or MEN2 syndrome, or have active pancreatitis. A physician will review your health history before approving any prescription.
Is MEDVi available in all U.S. states?
No. MEDVi’s availability depends on state telehealth regulations and compounding pharmacy licensing. Check the MEDVi website to confirm service in your state before starting the intake process.
What is the difference between semaglutide and tirzepatide?
Semaglutide is a single GLP-1 receptor agonist, while tirzepatide targets both GLP-1 and GIP receptors. This dual mechanism generally makes tirzepatide more effective for weight loss. For a detailed comparison, see our guide on the difference between semaglutide and tirzepatide.
How do I get started with MEDVi?
Visit the MEDVi program page here, complete the free online intake form, and a licensed physician will review your case typically within 24 to 48 hours.
References
[1] Medvi Review – https://clearmetabolic.com/reviews/medvi-review/
[3] Medvi Coupon Code 2026 Save Up To 30% On GLP-1 Weight Loss Plans – https://scribehow.com/page/MEDVi_Coupon_Code_2026_Save_Up_to_30percent_on_GLP-1_Weight_Loss_Plans__dw2v3OcsR4Cn_IohHMF-hg
[4] Medvi Reviews – https://peptidesexplorer.com/blog/medvi-reviews
[5] Medvi Tirzepatide Cost – https://www.blastfitness.com/medvi-tirzepatide-cost/
[6] Medvi Tirzepatide Reviews – https://weightlossrxreviews.com/medvi-tirzepatide-reviews/
[7] Medvi Tirzepatide Cost Complete Guide – https://www.seekpeptides.com/blog/articles/medvi-tirzepatide-cost-complete-guide
[8] Considering Medvi Tirzepatide GLP-1 – https://finance.yahoo.com/news/considering-medvi-tirzepatide-glp-1-011600156.html
[9] Best Compounded Tirzepatide Providers – https://plexusdx.com/blogs/learn/best-compounded-tirzepatide-providers-plexusdx
[10] Medvi – Consumer Affairs – https://www.consumeraffairs.com/health/medvi.html
Tags: MEDVi tirzepatide, tirzepatide cost, compounded tirzepatide, GLP-1 weight loss, telehealth weight loss, tirzepatide vs semaglutide, weight loss medication cost, Zepbound alternative, GLP-1 without insurance, MEDVi review, tirzepatide 2026, affordable tirzepatide
